Global Immunodiagnostics Market Size, Share, Trends, And Forecast, 2026-2033 Market To Reach USD 48.1 Billion As High-Sensitivity Biomarker Testing Drives Growth
Dublin, Nov. 18, 2026 (GLOBE NEWSWIRE) -- "Immunodiagnostics Market Size, Share & Trends Analysis Report 2026-2033" has been added to ResearchAndMarkets.com's offering.
The global immunodiagnostics market was valued at USD 30.9 billion in 2025 and is projected to increase from USD 32.5 billion in 2026 to USD 48.1 billion by 2033. The market is expected to expand at a compound annual growth rate of 5.8% from 2026 to 2033. North America led the global market in 2025, accounting for the largest revenue share of 37.1%.
Market growth is being supported by the increasing prevalence of chronic diseases and the expanding adoption of high-sensitivity biomarker-based immunodiagnostic testing. Rising cases of cardiovascular diseases, cancer, diabetes, autoimmune disorders, neurological diseases, and other chronic conditions are generating sustained demand for sensitive, specific, and scalable diagnostic assays.
Healthcare providers are increasingly using immunodiagnostic testing to support early disease detection, differential diagnosis, disease monitoring, and treatment selection. Continued advances in assay performance, laboratory automation, diagnostic platforms, and biomarker research are also expected to improve testing capabilities and create growth opportunities across hospitals, laboratories, and other healthcare settings.
Market Segmentation Covered in the Report
The report provides country-level revenue forecasts and evaluates industry trends, market drivers, competitive developments, and emerging opportunities across product, technology, application, end use, and regional segments from 2021 to 2033.
Product Outlook (Revenue, USD Billion, 2021 - 2033)
- Reagents & Consumables Instruments Software & Services
Technology Outlook (Revenue, USD Billion, 2021 - 2033)
- Chemiluminescence Immunoassay Enzyme-Linked Immunosorbent Assay Fluorescence Immunoassay Rapid Immunochromatographic Assay Radioimmunoassay Immunoturbidimetry & Nephelometry Immunoblot Assay Other Technologies
Application Outlook (Revenue, USD Billion, 2021 - 2033)
- Infectious Disease Testing Oncology Testing Cardiac Testing Endocrinology Testing Autoimmune Disease Testing Allergy Testing Women's Health & Reproductive Testing Bone, Anemia & Nutritional Testing Therapeutic Drug Monitoring & Toxicology Neurological Testing Other Applications
End Use Outlook (Revenue, USD Billion, 2021 - 2033)
- Hospitals Laboratories Others
Regional Outlook (Revenue, USD Billion; 2021 - 2033)
- North America: U.S., Canada, and Mexico Europe: UK, Germany, France, Italy, Spain, Norway, Denmark, and Sweden Asia Pacific: Japan, China, India, Australia, South Korea, and Thailand Latin America: Brazil and Argentina Middle East & Africa: South Africa, Saudi Arabia, UAE, and Kuwait
Strategic Value of the Report
The report delivers comprehensive immunodiagnostics market analysis across major geographic and industry segments. It examines the competitive landscape, including the market presence and strategic positioning of key participants, while identifying the trends expected to shape future demand.
- Market intelligence designed to support informed business and investment decisions Historical market estimates and long-term revenue forecasts Analysis of growth opportunities, industry trends, and demand drivers Segment-level and regional revenue projections for market assessment Competitive strategy and market share analysis Coverage of product innovation and evolving diagnostic technologies Actionable insights for identifying revenue opportunities and guiding strategic planning
With demand for accurate and scalable diagnostics continuing to rise, the report helps industry participants evaluate the global immunodiagnostics market, identify attractive segments, assess regional opportunities, monitor competitive activity, and develop strategies aligned with changing clinical and commercial requirements.
Key Topics Covered:
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Technology Segment
1.2.3. Application Segment
1.2.4. End Use Segment
1.3. Information Procurement
1.3.1. Primary Infectious Disease Testing
1.4. Information and Data Analysis
1.4.1. Market Formulation & Data Visualization
1.5. Market Model
1.6. Data Validation & Publishing
1.7. Total Market: CAGR Calculation
1.8. Objectives
1.8.1. Objective 1
1.8.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Global Immunodiagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Market Opportunity Analysis
3.3. Global Immunodiagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.2. PESTEL Analysis
Chapter 4. Global Immunodiagnostics Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Immunodiagnostics Market Product Movement Analysis
4.3. Global Immunodiagnostics Market Size & Trend Analysis, Product, 2021 to 2033 (USD Billion)
4.4. Reagents & Consumables
4.4.1. Reagents & Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
4.5. Instruments
4.5.1. Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
4.6. Software & Services
4.6.1. Software & Services Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 5. Global Immunodiagnostics Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Immunodiagnostics Market Technology Movement Analysis
5.3. Global Immunodiagnostics Market Size & Trend Analysis, Technology, 2021 to 2033 (USD Billion)
5.4. Chemiluminescence Immunoassay
5.4.1. Chemiluminescence Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
5.5. Enzyme-Linked Immunosorbent Assay
5.5.1. Enzyme-Linked Immunosorbent Assay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
5.6. Fluorescence Immunoassay
5.6.1. Fluorescence Immunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
5.7. Rapid Immunochromatographic Assay
5.7.1. Rapid Immunochromatographic Assay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
5.8. Radioimmunoassay
5.8.1. Radioimmunoassay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
5.9. Immunoturbidimetry & Nephelometry
5.9.1. Immunoturbidimetry & Nephelometry Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
5.10. Immunoblot Assay
5.10.1. Immunoblot Assay Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
5.11. Other Technologies
5.11.1. Other Technologies Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 6. Global Immunodiagnostics Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Immunodiagnostics Market Application Movement Analysis
6.2.1. Global Immunodiagnostics Market Size & Trend Analysis, Application, 2021 to 2033 (USD Billion)
6.3. Infectious Disease Testing
6.3.1. Infectious Disease Testing Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
6.4. Oncology Testing
6.4.1. Oncology Testing Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
6.5. Cardiac Testing
6.5.1. Cardiac Testing Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
6.6. Endocrinology Testing
6.6.1. Endocrinology Testing Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
6.7. Autoimmune Disease Testing
6.7.1. Autoimmune Disease Testing Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
6.8. Allergy Testing
6.8.1. Allergy Testing Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
6.9. Women's Health & Reproductive Testing
6.9.1. Women's Health & Reproductive Testing Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
6.10. Bone, Anemia & Nutritional Testing
6.10.1. Bone, Anemia & Nutritional Testing Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
6.11. Therapeutic Drug Monitoring & Toxicology
6.11.1. Therapeutic Drug Monitoring & Toxicology Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
6.12. Neurological Testing
6.12.1. Neurological Testing Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
6.13. Other Applications
6.13.1. Other Applications Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 7. Global Immunodiagnostics Market: End-use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Immunodiagnostics Market End-use Movement Analysis
7.2.1. Global Immunodiagnostics Market Size & Trend Analysis, End-use, 2021 to 2033 (USD Billion)
7.3. Hospitals & Clinics
7.3.1. Hospitals & Clinics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.4. Diagnostic Laboratories
7.4.1. Diagnostic Laboratories Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.5. Blood Banks & Plasma Screening Centers
7.5.1. Blood Banks & Plasma Screening Centers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.6. Home-Care Settings
7.6.1. Home-Care Settings Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 8. Immunodiagnostics Market: Regional Estimates & Trend Analysis
8.1. Regional Dashboard
8.2. Market Size & Forecast Trend Analysis, 2021 to 2033
8.2.1. Country Analyses: Key Dynamics, Regulatory Framework/Reimbursement Structure, Competitive Scenario, and Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
8.3. North America
8.3.1. U.S.
8.3.2. Canada
8.3.3. Mexico
8.4. Europe
8.4.1. Germany
8.4.2. UK
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Norway
8.4.7. Sweden
8.4.8. Denmark
8.5. Asia Pacific
8.5.1. Japan
8.5.2. China
8.5.3. India
8.5.4. Australia
8.5.5. South Korea
8.5.6. Thailand
8.6. Latin America
8.6.1. Brazil
8.6.2. Argentina
8.7. MEA
8.7.1. South Africa
8.7.2. Saudi Arabia
8.7.3. UAE
8.7.4. Kuwait
Chapter 9. Competitive Landscape
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Share Analysis, 2025
9.4. Company Profiles/Listing
9.4.1. Profile Analysis: Company Overview, Financial Performance, Product Benchmarking, and Strategic Initiatives
9.4.2. F. Hoffmann-La Roche Ltd.
9.4.3. Abbott
9.4.4. Siemens Healthineers
9.4.5. Beckman Colter, Inc.
9.4.6. BIOMERIEUX
9.4.7. DiaSorin S.p.A.
9.4.8. QuidelOrtho Corporation
9.4.9. Thermo Fisher Scientific Inc.
9.4.10. Bio-Rad Laboratories, Inc.
9.4.11. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
List of Tables [121]
List of Figures [81]
Companies Featured
- F. Hoffmann-La Roche Ltd. Abbott Siemens Healthineers Beckman Colter, Inc. BIOMERIEUX DiaSorin S.p.A. QuidelOrtho Corporation Thermo Fisher Scientific Inc. Bio-Rad Laboratories, Inc. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
For more information about this report visit
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.

Comments
No comment